These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38574630)

  • 21. The HNF1A-AS1/miR-92a-3p axis affects the radiosensitivity of non-small cell lung cancer by competitively regulating the JNK pathway.
    Wang Z; Liu L; Du Y; Mi Y; Wang L
    Cell Biol Toxicol; 2021 Oct; 37(5):715-729. PubMed ID: 33755848
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exosomal microRNA-144 from bone marrow-derived mesenchymal stem cells inhibits the progression of non-small cell lung cancer by targeting CCNE1 and CCNE2.
    Liang Y; Zhang D; Li L; Xin T; Zhao Y; Ma R; Du J
    Stem Cell Res Ther; 2020 Feb; 11(1):87. PubMed ID: 32102682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SIRT6 through PI3K/Akt/mTOR signaling pathway to enhance radiosensitivity of non-Small cell lung cancer and inhibit tumor progression.
    Xiong L; Tan B; Lei X; Zhang B; Li W; Liu D; Xia T
    IUBMB Life; 2021 Sep; 73(9):1092-1102. PubMed ID: 34033225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. EZH2 affects malignant progression and DNA damage repair of lung adenocarcinoma cells by regulating RAI2 expression.
    Huang M; Ding J; Wu X; Peng X; Wu G; Peng C; Zhang H; Mao C; Huang B
    Mutat Res; 2022; 825():111792. PubMed ID: 35939884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemotherapy-elicited exosomal miR-378a-3p and miR-378d promote breast cancer stemness and chemoresistance via the activation of EZH2/STAT3 signaling.
    Yang Q; Zhao S; Shi Z; Cao L; Liu J; Pan T; Zhou D; Zhang J
    J Exp Clin Cancer Res; 2021 Apr; 40(1):120. PubMed ID: 33823894
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
    Lu C; Shan Z; Hong J; Yang L
    Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LncRNA NEAT1 induces autophagy through the miR-128-3p/ADAM28 axis to suppress apoptosis of nonsmall-cell lung cancer.
    Xie Y; Zheng ZW; He HT; Chang ZB
    Kaohsiung J Med Sci; 2022 Oct; 38(10):933-949. PubMed ID: 36054559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MiR-101-3p inhibits the growth and metastasis of non-small cell lung cancer through blocking PI3K/AKT signal pathway by targeting MALAT-1.
    Zhang X; He X; Liu Y; Zhang H; Chen H; Guo S; Liang Y
    Biomed Pharmacother; 2017 Sep; 93():1065-1073. PubMed ID: 28738500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypoxic bone marrow mesenchymal cell-extracellular vesicles containing miR-328-3p promote lung cancer progression via the NF2-mediated Hippo axis.
    Liu X; Jiang F; Wang Z; Tang L; Zou B; Xu P; Yu T
    J Cell Mol Med; 2021 Jan; 25(1):96-109. PubMed ID: 33219752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-631 deriving from bone marrow mesenchymal stem cell exosomes facilitates the malignant behavior of non-small cell lung cancer via modulating the E2F family of transcription factor 2/phosphatidylinositol 3-kinase/Akt signaling pathway.
    Lv H; Yu J; Zhang H; Qian X; Wang Q; Lu B; Sun Y
    Bioengineered; 2022 Apr; 13(4):8382-8395. PubMed ID: 35353027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exosomal microRNA-125a-3p from human adipose-derived mesenchymal stem cells promotes angiogenesis of wound healing through inhibiting PTEN.
    Pi L; Yang L; Fang BR; Meng XX; Qian L
    Mol Cell Biochem; 2022 Jan; 477(1):115-127. PubMed ID: 34581942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mesenchymal stem cell-derived exosomal miR-143-3p suppresses myocardial ischemia-reperfusion injury by regulating autophagy.
    Chen G; Wang M; Ruan Z; Zhu L; Tang C
    Life Sci; 2021 Sep; 280():119742. PubMed ID: 34166712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of microRNA-21 in radiosensitivity in non-small cell lung cancer cells by targeting PDCD4 gene.
    Jiang LP; He CY; Zhu ZT
    Oncotarget; 2017 Apr; 8(14):23675-23689. PubMed ID: 28423589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway.
    Wei CH; Wu G; Cai Q; Gao XC; Tong F; Zhou R; Zhang RG; Dong JH; Hu Y; Dong XR
    J Hematol Oncol; 2017 Jun; 10(1):125. PubMed ID: 28629431
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-101 exerts tumor-suppressive functions in non-small cell lung cancer through directly targeting enhancer of zeste homolog 2.
    Zhang JG; Guo JF; Liu DL; Liu Q; Wang JJ
    J Thorac Oncol; 2011 Apr; 6(4):671-8. PubMed ID: 21270667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exosomal circ_PIP5K1A regulates the progression of non-small cell lung cancer and cisplatin sensitivity by miR-101/ABCC1 axis.
    Shao N; Song L; Sun X
    Mol Cell Biochem; 2021 Jun; 476(6):2253-2267. PubMed ID: 33570734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exosomal microRNA-551b-3p from bone marrow-derived mesenchymal stromal cells inhibits breast cancer progression via regulating TRIM31/Akt signaling.
    Yang Z; Xu B; Wu S; Yang W; Luo R; Geng S; Xin Z; Jin W; Shen X; Gu X; Zhang H; Wang H
    Hum Cell; 2022 Nov; 35(6):1797-1812. PubMed ID: 35941326
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MiR-142-3p Overexpression Increases Chemo-Sensitivity of NSCLC by Inhibiting HMGB1-Mediated Autophagy.
    Chen Y; Zhou X; Qiao J; Bao A
    Cell Physiol Biochem; 2017; 41(4):1370-1382. PubMed ID: 28427045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dysregulated
    Sui J; Zhao Q; Zhang Y; Liang G
    DNA Cell Biol; 2022 Mar; 41(3):319-329. PubMed ID: 35244469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Translation regulatory long non-coding RNA 1 negatively regulates cell radiosensitivity via the miR-22-3p/SP1 axis in non-small cell lung cancer.
    Zhong M; Fang Z; Guo W; Yu X
    Clin Respir J; 2024 Jan; 18(1):e13734. PubMed ID: 38286742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.